Vela Diagnostics Signs Collaboration Agreements With Eppendorf

SINGAPORE, July 12, 2012 /PRNewswire/ --

Vela Diagnostics and Eppendorf have agreed to jointly develop an IVD RNA/DNA extraction platform - called "Sentosa SX". The new system is based on Eppendorf's world class pipetting and liquid handling technology and Vela's broad IVD and workflow know-how.

Following on the deal, VelaDx and Eppendorf scientists and engineers have customized Eppendorf's epMotion system with an efficient diagnostic workflow and features exclusive to VelaDx. The enhancements focused on gaining workflow efficiency and IT connectivity, while minimizing potential errors and cross contamination arising from manual set up processes. The "Sentosa SX" platform is uniquely able to set up and simultaneously carry out four different tests per run.

Commenting on the joint development, VelaDx CEO Michael Tillmann said, "Our collaboration merges an already robust epMotion with revolutionary system enhancements. The new customized hardware and software on the "Sentosa SX" system will enhance workflow efficiency in laboratories and improve sample traceability.  It will be easier for lab staff and they can maximize their time in other value adding tasks."

The new "Sentosa SX" extraction platform connects with VelaDx's PCR detection.  The Company's "Sentosa" workflow systems and "Sentosa" test kits will be launched in selected Asian and European markets in Q3 2012.  The Group is also making submissions for regulatory approval in the US.

About Vela Diagnostics

VelaDx provides a broad menu of molecular diagnostic tests, consolidated on its automated "Sentosa" workflow system.  The Group was incorporated by an industry experienced management team in 2011 with the vision of providing in-vitro diagnostic solutions for customers to achieve improved laboratory management.  VelaDx is a privately owned Group of Companies headquartered in Singapore.  The Asia Pacific, European and North American commercial operations of the Group are based in Singapore, Hamburg and New Jersey, respectively.  VelaDx also operates R&D sites in Singapore and New Jersey in addition to a Global Manufacturing facility in Singapore. For more information, please visit us at http://www.veladx.com

Contact:

Peter Matthiesen
Vela Diagnostics Germany GmbH
e-Mail: peter.matthiesen@veladx.com,
Telefon: +49(40)890662-230